The groundbreaking rise of Viagra has long been a benchmark of pharmaceutical success, yet its legacy within the broader sector now raises questions about long-term gains. Generic versions are eroding https://bookmarkbooth.com/story21503224/the-blue-diamond-and-drug-companies-a-risky-opportunity